To eradicate Helicobacter Pylori, Biaksin Filmtab, as described below, be administered in combination with other agents adults. Eradication of H. pylori has been shown to reduce the risk of recurrence of duodenal ulcer [see Clinical Studies (14.3)].
Biaksin Filmtab delayed-release capsules in combination with amoxicillin and Prevacid (lansoprazole) or Prilosec (omeprazole) as a combination therapy of three drugs for the treatment of patients with active or 5-year history of infection H. Pylori and duodenal ulcer (DU has been shown a plague to eradicate H.).
Biaksin Filmtab combined with Prilosec is (omeprazole) capsules are indicated for the treatment of active duodenal ulcer associated with an infection H.pylori. Treatment regimen containing Biaksin Filmtab as the only antimicrobial agent, in patients who do not treat more likely due to the development of clarithromycin resistance. The effectiveness of treatment in order to reduce the settings in this mode, including clarithromycin should not be used in patients with known or suspected clarithromycin resistant isolates.
limiting the use of
Biaksin XL Filmtab only acute sinusitis, acute bacterial exacerbation of chronic bronchitis, and has been shown for pneumonia in adults. Efficacy and safety Biaksin XL Filmtab to treat other infections Biaksin Filmtab Biaksin granules and approved installed.
Biaxin for dogs
There is resistance to macrolides including bacterial infections caused by pneumococci and Staphylococcus aureus. You must perform testing for susceptibility to clinical indications.
In order to reduce the emergence of resistant bacteria, in order to maintain the effectiveness of Biaxin and other antimicrobial agents, Biaksin appears that caused by susceptible bacteria infections or strongly suspected to treat or prevent it should be used. If the information in the culture and sensitivity available, they should be considered when selecting or modifying antibacterial therapy.
Biaxin for dogs
If no such data local epidemiology and susceptibility patterns have been received to facilitate empirical treatment choice.